Solstein Capital’s Eastman Chemical EMN Stock Holding History

Solstein Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-90	Closed	-$4K	–	241
2020 Q1	$4K	Buy	+90	New	+$5.78K	0.02%	213

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Solstein Capital's EMN Position: Q2 2020 in Review

Solstein Capital sold out of Eastman Chemical (EMN) in Q2 2020, closing a stake of 90 shares — an estimated $4K sold.

Solstein Capital first reported a position in EMN in Q1 2020 and held it in 1 quarter. The position peaked at $4K in Q1 2020. 609 funds tracked by Wall St. Rank hold EMN as of Q2 2020.

Solstein Capital reported no remaining Eastman Chemical position as of Q2 2020 after selling out during the quarter.
Solstein Capital sold 90 Eastman Chemical shares in Q2 2020, an estimated $4K.
Solstein Capital first reported a position in Eastman Chemical in Q1 2020 and held it in 1 quarter.
Solstein Capital's Eastman Chemical position peaked at $4K in Q1 2020.
609 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2020.

Based on Solstein Capital's 13F filing for Q2 2020, filed 12 Aug 2020.